A frame from the final video containing human-hearable audio track showing grooming behavior and FM USV call at frame #50. by Piotr Popik (292215)

Copper ion concentration (A, Control; B, strain A; C, strain B; D, strain F) of MSM during fermentation for <i>S</i>. <i>cerevisiae</i> strains in MSM with 0 (control) (A*, B*, F*)... by Xiang-yu Sun (748032)

A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

RhoA-induced suppression of the HSR decreases cell stress resistance and induces cell death via apoptosis. by Roelien A. M. Meijering (217816)

Mycolactone induces a decrease in dermal collagen fibers. by José B. Gama (296675)

Decreased inflammatory markers of peritoneal macrophages following <i>in vivo</i> treatment with p30A peptide. by Jérôme Rambert (46851)

ATG 5 down-regulation decreases human A53T ASYN-induced death in rat cortical neurons. by Maria Xilouri (264240)

EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice. by Yona Goldshmit (205708)

“…Arrows indicate lesion site. Scale bars in A–D, G,H, 100 µm; E,F, 50 µm.</p>…”

BKM120 decreases cellular glycolytic metabolic activity in MB cell lines. by Ping Zhao (47228)

Kinetic properties of [³H] WIN35,428 and [³H] Nisoxetine binding in PC12 cells expressing WT hNET and its mutants. by Matthew J. Strauss (13876538)

Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

Subjects:

Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

Subjects:

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Subjects:

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

EQI decreases malonyl-CoA levels in <i>S</i>. <i>aureus</i>. by Erica C. Larson (1344687)

Dominant negative Rac1 and Rac1 siRNA both decrease H₂S-promoted cell migration and tube formation in HUVECs. by Li-Jia Zhang (308411)